And breast cancer cell-derived IL-18 also predicts a bad prognosis in patients with TNBC by increasing the immunosuppressive CD56dimCD16dim/- NK cell fraction and inducing PD-1 expression on NK cells [43]. Here, IL18 is linked to breast carcinoma.